Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study

By Louise Arseneault, M. Cannon, Richie Poulton, Robin M. Murray, Avshalom Caspi, Terrie E. Moffitt. British medical journal, 2002

1,412 citations recorded by the source corpus.

Subfields: Oncology, Physiology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/38ac07dcd823e9e9745afed39744608723153262

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. J. van Os
2. R. Linscott
3. I. Myin‐Germeys
4. P. Delespaul
5. Lydia Krabbendam
6. Deepak Cyril D'Souza
7. Gabriel Braley
8. Ralitza Gueorguieva

Citations in the corpus

• Cannabis and the brain. (2003, background): “In addition, further reports from New Zealand (Arseneault et al., 2002; Fergusson et al., 2003), Australia (Patton et al.”
• A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness–persistence–impairment model of psychotic disorder (2008, background): “…exclusion criteria, reported on the effects of exposure to risk factors, and, consequently, were included in this analysis (van Os et al. 2001, 2003 ; Arseneault et al. 2002 ; Goodwin et al. 2003 ; Janssen et al. 2003, 2004 ; Maric et al. 2003 ; Spauwen et al. 2004, 2006b ; Fergusson et al. 2005).”
• The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis (2004, background): “…literature from pharmacological (Jones, 1971; Leweke et al, 2000, 1999b; McGuire et al, 1995), epidemiological (Andreasson et al, 1987, 1988, 1989; Arseneault et al, 2002; McGuire et al, 1995; Zammit et al, 2002), genetic (Ujike et al, 2002), neurochemical (Leweke et al, 1999a), and postmortem…”